These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35150139)

  • 41. Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY): effects of chitosan concentration.
    Li XY; Jin LJ; Lu YN; Zhen YH; Li SY; Wang LH; Xu YP
    Appl Biochem Biotechnol; 2009 Dec; 159(3):778-87. PubMed ID: 19412580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of apoptosis in HeLa cancer cells by an ultrasonic-mediated synthesis of curcumin-loaded chitosan-alginate-STPP nanoparticles.
    Ahmadi F; Ghasemi-Kasman M; Ghasemi S; Gholamitabar Tabari M; Pourbagher R; Kazemi S; Alinejad-Mir A
    Int J Nanomedicine; 2017; 12():8545-8556. PubMed ID: 29238191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
    Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R
    AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.
    Hagras NA; Mogahed NMFH; Sheta E; Darwish AA; El-Hawary MA; Hamed MT; Elwakil BH
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010268. PubMed ID: 35294434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chitosan/alginate nanoparticles as a promising carrier of novel curcumin diethyl diglutarate.
    Sorasitthiyanukarn FN; Ratnatilaka Na Bhuket P; Muangnoi C; Rojsitthisak P; Rojsitthisak P
    Int J Biol Macromol; 2019 Jun; 131():1125-1136. PubMed ID: 30902713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery.
    Wang FQ; Li P; Zhang JP; Wang AQ; Wei Q
    Drug Dev Ind Pharm; 2010 Jul; 36(7):867-77. PubMed ID: 20345282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a novel drug delivery system: chitosan nanoparticles entrapped in alginate microparticles.
    Garrait G; Beyssac E; Subirade M
    J Microencapsul; 2014; 31(4):363-72. PubMed ID: 24697173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Statistical Study on the Development of Metronidazole-Chitosan-Alginate Nanocomposite Formulation Using the Full Factorial Design.
    Sabbagh HAK; Hussein-Al-Ali SH; Hussein MZ; Abudayeh Z; Ayoub R; Abudoleh SM
    Polymers (Basel); 2020 Apr; 12(4):. PubMed ID: 32244671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Properties of an alginate gel bead containing a chitosan-drug salt.
    Murata Y; Hirai D; Kofuji K; Miyamoto E; Kawashima S
    Biol Pharm Bull; 2004 Mar; 27(3):440-2. PubMed ID: 14993820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules.
    Goycoolea FM; Lollo G; Remuñán-López C; Quaglia F; Alonso MJ
    Biomacromolecules; 2009 Jul; 10(7):1736-43. PubMed ID: 19545119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
    Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
    Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual-layered pH-sensitive alginate/chitosan/kappa-carrageenan microbeads for colon-targeted release of 5-fluorouracil.
    Sun X; Liu C; Omer AM; Yang LY; Ouyang XK
    Int J Biol Macromol; 2019 Jul; 132():487-494. PubMed ID: 30940590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alginate Calcium Microbeads Containing Chitosan Nanoparticles for Controlled Insulin Release.
    Li J; Wu H; Jiang K; Liu Y; Yang L; Park HJ
    Appl Biochem Biotechnol; 2021 Feb; 193(2):463-478. PubMed ID: 33026616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery.
    Gao P; Xia G; Bao Z; Feng C; Cheng X; Kong M; Liu Y; Chen X
    Int J Biol Macromol; 2016 Oct; 91():716-23. PubMed ID: 27287772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alginate-chitosan coated layered double hydroxide nanocomposites for enhanced oral vaccine delivery.
    Yu X; Wen T; Cao P; Shan L; Li L
    J Colloid Interface Sci; 2019 Nov; 556():258-265. PubMed ID: 31450020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.